Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People who do not have adequate amounts of vitamin D develop weakness of leg and arm muscles. This study will determine if vitamin D supplementation benefits muscle functions important for swallowing, bladder and bowel function.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment of Vitamin D Insufficiency

NCT00933244

Vitamin D Deficiency

COMPLETED PHASE4

Vitamin D Supplementation and Muscle Function in Older Adults

NCT02015611

Neuromuscular Function

COMPLETED NA

Vitamin D Supplementation and Physical Function in Older Adults

NCT01179503

Physical Function Vitamin D Insufficiency

COMPLETED EARLY_PHASE1

Effect of Vitamin D Supplementation on Muscle Mass and Function

NCT01199926

Obesity Insulin Resistance Inflammation

COMPLETED PHASE4

A Pilot Study of the Impact of Vitamin D3 on Muscle Performance in Elderly Women

NCT00986596

Sarcopenia Falls

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysphagia Fecal Incontinence Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

oral placebo 3 times weekly

Group Type PLACEBO_COMPARATOR

Ergocalciferol (vitamin D2)

Intervention Type OTHER

50,000 IU 3 times weekly for 4 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ergocalciferol (vitamin D2)

50,000 IU 3 times weekly for 4 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who present for evaluation to the UW Geriatric clinic including Dr. Pryzbelski's subspecialty, or Osteoporosis clinics
* Age 70 years or older
* Cognitively intact, as determined by the attending physicians at above mentioned clinics

Exclusion Criteria

* History of, on ongoing, renal failure
* History of liver failure
* Known malabsorption
* Known disorders of parathyroid function, hyper/hypocalcemia, or other abnormalities of calcium or phosphate metabolism
* Known history of vitamin D intoxication or granulomatous disease
* active seizure disorder
* Pain associated with temporomandibular joint (TMJ)

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes